Kharazmi Elham, Babaei Masoud, Fallah Mahdi, Chen Tianhui, Sundquist Kristina, Hemminki Kari
Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany,
Division of Preventive Oncology, National Center for Tumor Diseases, Heidelberg, Germany,
Clin Epidemiol. 2018 Sep 4;10:1169-1179. doi: 10.2147/CLEP.S168152. eCollection 2018.
Familial clustering of upper gastrointestinal (UGI) cancers and the significance of family history has been addressed previously. We aimed to elucidate the familial risk based on the specified tumor location and histology.
In the Swedish Family-Cancer Database, we determined the familial risk of UGI cancer patients diagnosed (1958-2015) with esophageal and gastric cancer by tumor location using standardized incidence ratios (SIRs).
Risk of esophageal cancer in first-degree relatives (FDRs) of patients with esophageal cancer increased 2.4-fold (SIR 95% CI 2.0-2.8), whereas risk of esophageal cancer in cases with family history of cancer in the middle third of the esophagus increased 3.4-fold (SIR 95% CI 2.1-5.1). Risk of gastric cancer in FDRs increased 1.6-fold (SIR 95% CI 1.5-1.7), occurrence of concordant subsite gastric cancer in the antrum, body, and cardia was 5.5-fold (SIR 95% CI 2.4-11), 4.6-fold (SIR 95% CI 2.6-7.4), and 1.7-fold (SIR 95% CI 1.1-2.5), respectively. Familial risk of concordant histological subtype in esophageal cancer was 4.1-fold for squamous cell carcinoma (SIR 95% CI 3.2-5.2) and 3.6-fold for adenocarcinoma (SIR 95% CI 2.5-5.1). The risk of concordant gastric adenocarcinoma was 1.6-fold for one affected FDR (SIR 95% CI 1.5-1.7), 6.1-fold for two FDRs (SIR 95% CI 4.4-8.4), and 8.6-fold among twins (SIR 95% CI 2.3-22).
Family history of cancer in the lower third of the esophagus and stomach cancer in specific locations such as the antrum, body, and cardia can be considered as important predictive evidence for cancer in the same location in relatives. Our findings might guide endoscopy-based surveillance by introducing subgroups of populations with a higher risk for UGI cancer with particular attention to concordance of location of lesions, which could be a reasonable strategy for early detection, and thus help save more lives.
上消化道(UGI)癌症的家族聚集性以及家族史的意义此前已有研究。我们旨在根据特定的肿瘤位置和组织学来阐明家族风险。
在瑞典家族癌症数据库中,我们通过标准化发病比(SIR),根据肿瘤位置确定了1958 - 2015年诊断为食管癌和胃癌的UGI癌症患者的家族风险。
食管癌患者的一级亲属(FDR)患食管癌的风险增加了2.4倍(SIR 95% CI 2.0 - 2.8),而食管中三分之一有癌症家族史的患者患食管癌的风险增加了3.4倍(SIR 95% CI 2.1 - 5.1)。FDR患胃癌的风险增加了1.6倍(SIR 95% CI 1.5 - 1.7),胃窦、胃体和贲门处一致性亚部位胃癌的发生率分别为5.5倍(SIR 95% CI 2.4 - 11)、4.6倍(SIR 95% CI 2.6 - 7.4)和1.7倍(SIR 95% CI 1.1 - 2.5)。食管癌中组织学亚型一致的家族风险,鳞状细胞癌为4.1倍(SIR 95% CI 3.2 - 5.2),腺癌为3.6倍(SIR 95% CI 2.5 - 5.1)。一致性胃腺癌的风险,有一名受影响FDR的为1.6倍(SIR 95% CI 1.5 - 1.7),有两名FDR的为6.1倍(SIR 95% CI 4.4 - 8.4),双胞胎中的为8.6倍(SIR 95% CI 2.3 - 22)。
食管下三分之一的癌症家族史以及胃窦、胃体和贲门等特定部位的胃癌家族史可被视为亲属中同一部位癌症的重要预测依据。我们的研究结果可能通过引入UGI癌症高风险人群亚组来指导基于内镜的监测,特别关注病变位置的一致性,这可能是早期检测的合理策略,从而有助于挽救更多生命。